BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) will hold a special shareholders’ meeting on June 30 as the company tries to avoid delisting from the Nasdaq, according to documents filed … Continued
Source: BizWest
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as…
LOVELAND — An ownership group for North Shore Manor in Loveland has filed for Chapter 11 bankruptcy protection and claims…
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) received a notice last week that it faces delisting from the stock exchange…
